
Doca-Pharma BV
Doca-Pharma (BV) is a company in Sint-Niklaas, active in veterinary activities, founded in 2024. Financial year 2025: gross margin -€27,380, profit -€64,546, equity -€79,753.
1 warning: negative equity1 seriousShowHide
- Explained →
Negative equity. Equity was € -79,753 in financial year 2025. Debts exceed what the company owns; the board must in principle follow the alarm bell procedure.
Source: NBB, 2025 annual accounts
Figures for Doca-Pharma, 2025NBB · micro format
All figures, sector and health →Three ratios
How we calculateAnnual accounts 2025. The sector is recalculated every night.
See everything about Doca-Pharma
Health check, financial year in detail, 10 years of history and the board.
What happenedfrom the annual accounts and the CBE
- Annual accounts 2025 filed
- Annual accounts 2024 filed
- Incorporated as besloten vennootschap
Establishments 1
- Edgar Tinelstraat 11, 9112 Sint-Niklaas · since 10/09/20242.363.815.368
Publications in the Belgian Official Gazette 1 publication
- 12/09/2024Incorporation and articlesOprichting (nieuwe rechtspersoon, opening bijkantoor, enz...)Deed (pdf)
To the publication → list, timeline or per year
E-invoicing and VAT
Checking… · Peppol network and European VAT register (VIES)Read more